ZBTB49
gene geneOn this page
Also known as FLJ38559
Summary
ZBTB49 (zinc finger and BTB domain containing 49, HGNC:19883) is a protein-coding gene on chromosome 4p16.3, encoding Zinc finger and BTB domain-containing protein 49 (Q6ZSB9). Transcription factor.
Enables DNA-binding transcription factor binding activity; sequence-specific DNA binding activity; and transcription coactivator binding activity. Involved in negative regulation of cell population proliferation; positive regulation of transcription by RNA polymerase II; and regulation of cell cycle. Located in cytosol; microtubule cytoskeleton; and nucleoplasm.
Source: NCBI Gene 166793 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 115 total
- MANE Select transcript:
NM_145291
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19883 |
| Approved symbol | ZBTB49 |
| Name | zinc finger and BTB domain containing 49 |
| Location | 4p16.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38559 |
| Ensembl gene | ENSG00000168826 |
| Ensembl biotype | protein_coding |
| OMIM | 616238 |
| Entrez | 166793 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 3 nonsense_mediated_decay
ENST00000337872, ENST00000502918, ENST00000503703, ENST00000504302, ENST00000511458, ENST00000515012, ENST00000880133, ENST00000880134, ENST00000924925, ENST00000942737
RefSeq mRNA: 2 — MANE Select: NM_145291
NM_001330625, NM_145291
CCDS: CCDS3375
Canonical transcript exons
ENST00000337872 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001161956 | 4306138 | 4306184 |
| ENSE00001816271 | 4290251 | 4290352 |
| ENSE00003473135 | 4301989 | 4303091 |
| ENSE00003526559 | 4313041 | 4313114 |
| ENSE00003529657 | 4320640 | 4321783 |
| ENSE00003556023 | 4315809 | 4315970 |
| ENSE00003558276 | 4315636 | 4315718 |
| ENSE00003630125 | 4299927 | 4300097 |
Expression profiles
Bgee: expression breadth ubiquitous, 187 present calls, max score 94.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8863 / max 74.3740, expressed in 1669 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46731 | 4.8863 | 1669 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 94.91 | gold quality |
| secondary oocyte | CL:0000655 | 93.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.10 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.31 | gold quality |
| ventricular zone | UBERON:0003053 | 80.28 | gold quality |
| granulocyte | CL:0000094 | 80.09 | gold quality |
| tibialis anterior | UBERON:0001385 | 78.77 | silver quality |
| cortical plate | UBERON:0005343 | 78.67 | gold quality |
| pituitary gland | UBERON:0000007 | 77.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.96 | gold quality |
| adenohypophysis | UBERON:0002196 | 76.66 | gold quality |
| gastrocnemius | UBERON:0001388 | 75.82 | gold quality |
| muscle of leg | UBERON:0001383 | 75.53 | gold quality |
| right ovary | UBERON:0002118 | 75.21 | gold quality |
| blood | UBERON:0000178 | 74.96 | gold quality |
| popliteal artery | UBERON:0002250 | 74.77 | gold quality |
| tibial artery | UBERON:0007610 | 74.77 | gold quality |
| leukocyte | CL:0000738 | 74.73 | gold quality |
| monocyte | CL:0000576 | 74.42 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 74.25 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 74.20 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.09 | gold quality |
| tendon | UBERON:0000043 | 74.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.93 | gold quality |
| spleen | UBERON:0002106 | 73.83 | gold quality |
| left ovary | UBERON:0002119 | 73.69 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.58 | gold quality |
| aorta | UBERON:0000947 | 73.44 | gold quality |
| ectocervix | UBERON:0012249 | 73.43 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 73.13 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 151.05 |
| E-MTAB-6379 | no | 173.15 |
| E-ANND-3 | no | 2.22 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting ZBTB49, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-187-5P | 99.74 | 70.26 | 1404 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-2054 | 99.20 | 68.89 | 1699 |
| HSA-MIR-6807-5P | 97.51 | 64.25 | 1046 |
| HSA-MIR-4794 | 96.47 | 65.53 | 1063 |
| HSA-MIR-6760-3P | 96.35 | 68.31 | 1001 |
| HSA-MIR-664A-5P | 95.84 | 64.93 | 949 |
Literature-anchored findings (GeneRIF, showing 2)
- Two major ZNF509 isoforms are induced by p53 and act as downstream executioners of cell-cycle arrest by inducing expression of p21 and RB. (PMID:25245946)
- ZNF509S1 modulation of p53 activity. (PMID:28757384)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zbtb49 | ENSDARG00000102111 |
| mus_musculus | Zbtb49 | ENSMUSG00000029127 |
| rattus_norvegicus | Zbtb49 | ENSRNOG00000005633 |
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB6 (ENSG00000186130), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 49 — Q6ZSB9 (reviewed: Q6ZSB9)
Alternative names: Zinc finger protein 509
All UniProt accessions (6): Q6ZSB9, D6RB16, D6RC96, D6RJ00, H0Y8P2, H0YAD4
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor. Inhibits cell proliferation by activating either CDKN1A/p21 transcription or RB1 transcription. Binds CDKN1A promoter and activates its transcription; this activity is further potentiated in the presence of EP300 (synergistic) and ZBTB17/Miz-1 (additive). Activates RB1 transcription most probably by antagonizing ZBTB17 repression of RB1. Does not bind directly RB1 promoter.
Subunit / interactions. Isoform 1 interacts with EP300 and KAT5/Tip60. The interaction with EP300 is direct and leads to synergistic induction of CDKN1A. On the CDKN1A promoter, forms a complex with ZBTB17/Miz-1; this interaction leads to additive CDKN1A transactivation. Isoform 3 also interacts with ZBTB17; this interaction may block ZBTB17 repressor activity.
Subcellular location. Cytoplasm. Nucleus Cytoplasm. Nucleus.
Tissue specificity. Highly expressed in normal epidermis and in other epithelial tissues, including in colon and lung. Tends to be down-regulated in colon, lung and skin cancer tissues.
Induction. Induced by the DNA-damaging agent etoposide. This induction is mediated by TP53 at the transcriptional level.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZSB9-1 | 1, ZNF509L | yes |
| Q6ZSB9-2 | 2 | |
| Q6ZSB9-3 | 3, ZNF509S1 | |
| Q6ZSB9-4 | 4, ZNF509S2 | |
| Q6ZSB9-5 | 5, ZNF509S3 |
RefSeq proteins (2): NP_001317554, NP_660334* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00096, PF00651, PF13912
UniProt features (24 total): zinc finger region 7, splice variant 6, sequence variant 4, sequence conflict 3, region of interest 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZSB9-F1 | 57.70 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 53 (showing top):
CMYB_01, USF_C, MYCMAX_01, GOBP_CYTOKINE_PRODUCTION, GOBP_REGULATION_OF_CELL_CYCLE, chr4p16, GOMF_TRANSCRIPTION_COREGULATOR_BINDING, GOMF_TRANSCRIPTION_COACTIVATOR_BINDING, GOMF_TRANSCRIPTION_FACTOR_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING
GO Biological Process (8): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682), negative regulation of cell population proliferation (GO:0008285), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of cell cycle (GO:0051726), pyrimidine nucleotide biosynthetic process (GO:0006221), positive regulation of DNA-templated transcription (GO:0045893)
GO Molecular Function (9): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), transcription coactivator binding (GO:0001223), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA-binding transcription factor binding (GO:0140297), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), cytosol (GO:0005829), microtubule cytoskeleton (GO:0015630)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| negative regulation of cellular process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| cell cycle | 1 |
| regulation of cellular process | 1 |
| pyrimidine nucleotide metabolic process | 1 |
| nucleotide biosynthetic process | 1 |
| pyrimidine-containing compound biosynthetic process | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription coregulator binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| transcription factor binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
| cytoskeleton | 1 |
Protein interactions and networks
STRING
440 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB49 | TMEM128 | Q5BJH2 | 573 |
| ZBTB49 | MSC | O60682 | 456 |
| ZBTB49 | LYAR | Q9NX58 | 438 |
| ZBTB49 | STX18 | Q9P2W9 | 406 |
| ZBTB49 | OTOP1 | Q7RTM1 | 358 |
| ZBTB49 | NSG1 | P42857 | 349 |
| ZBTB49 | THAP1 | Q9NVV9 | 338 |
| ZBTB49 | ZNF862 | O60290 | 327 |
| ZBTB49 | RALGAPA2 | Q2PPJ7 | 306 |
| ZBTB49 | STK32B | Q9NY57 | 302 |
| ZBTB49 | MEAF6 | Q9HAF1 | 283 |
| ZBTB49 | STRADB | Q9C0K7 | 279 |
| ZBTB49 | CHORDC1 | Q9UHD1 | 277 |
| ZBTB49 | ZBTB41 | Q5SVQ8 | 276 |
| ZBTB49 | EVC | P57679 | 271 |
| ZBTB49 | TAC4 | Q86UU9 | 271 |
IntAct
57 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP70 | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZBTB49 | GOPC | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZBTB49 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.740 |
| GOPC | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.740 |
| FBXL17 | BACH1 | psi-mi:“MI:0914”(association) | 0.730 |
| ZBTB49 | ZBTB8A | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZBTB8A | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZBTB49 | GOPC | psi-mi:“MI:0915”(physical association) | 0.560 |
| VAC14 | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF3 | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB49 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB49 | ZBTB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF2 | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB49 | CIB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB49 | ATP1A3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB49 | PECAM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VHL | ZBTB49 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (42): ZBTB49 (Two-hybrid), ZBTB49 (Two-hybrid), ZBTB49 (Two-hybrid), ZBTB8A (Two-hybrid), KAT5 (Affinity Capture-Western), EP300 (Affinity Capture-Western), EP300 (Reconstituted Complex), ZBTB49 (Reconstituted Complex), ZBTB17 (FRET), ZBTB17 (Co-localization), ZBTB17 (Affinity Capture-Western), ZBTB49 (Affinity Capture-Western), HINFP (Affinity Capture-Western), ZBTB49 (Affinity Capture-Western), HINFP (Co-localization)
ESM2 similar proteins: A0A1D5NS60, A0JN76, A1YFX5, A2T7G6, A6NJL1, D2HQI1, F1MJR8, O14901, P0CG00, P10754, P22227, P98182, Q0IJ29, Q1L8W0, Q3SWU4, Q5DW34, Q5EAC5, Q5EXX3, Q5RHB5, Q5SXI5, Q5T619, Q66H04, Q6NRM8, Q6NV66, Q6ZSB9, Q7M6U3, Q7TS63, Q7TSH3, Q7ZWZ4, Q801P1, Q86VK4, Q8BKX7, Q8BXX2, Q8NAM6, Q8NAP3, Q8NCP5, Q8R0A2, Q91VW9, Q96IT1, Q96N77
Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
115 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 8 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1647 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:4290351:GG:G | donor_gain | 1.0000 |
| 4:4290352:GG:G | donor_gain | 1.0000 |
| 4:4300035:G:GA | donor_gain | 1.0000 |
| 4:4300095:TAGG:T | donor_loss | 1.0000 |
| 4:4300096:AGG:A | donor_loss | 1.0000 |
| 4:4300099:T:G | donor_loss | 1.0000 |
| 4:4313039:A:AG | acceptor_gain | 1.0000 |
| 4:4313039:A:C | acceptor_loss | 1.0000 |
| 4:4313039:AG:A | acceptor_gain | 1.0000 |
| 4:4313040:G:GG | acceptor_gain | 1.0000 |
| 4:4313040:GG:G | acceptor_gain | 1.0000 |
| 4:4313040:GGC:G | acceptor_gain | 1.0000 |
| 4:4313040:GGCA:G | acceptor_gain | 1.0000 |
| 4:4313112:GAG:G | donor_gain | 1.0000 |
| 4:4313112:GAGGT:G | donor_loss | 1.0000 |
| 4:4313113:AGGTC:A | donor_loss | 1.0000 |
| 4:4313114:GG:G | donor_loss | 1.0000 |
| 4:4313115:G:GA | donor_loss | 1.0000 |
| 4:4313116:T:A | donor_loss | 1.0000 |
| 4:4315725:C:G | donor_gain | 1.0000 |
| 4:4290319:GA:G | donor_gain | 0.9900 |
| 4:4290321:G:GG | donor_gain | 0.9900 |
| 4:4299924:TAG:T | acceptor_loss | 0.9900 |
| 4:4299925:A:AG | acceptor_gain | 0.9900 |
| 4:4299925:A:G | acceptor_loss | 0.9900 |
| 4:4299926:G:GG | acceptor_gain | 0.9900 |
| 4:4300098:G:GG | donor_gain | 0.9900 |
| 4:4300767:G:GT | donor_gain | 0.9900 |
| 4:4301986:CAG:C | acceptor_loss | 0.9900 |
| 4:4301987:A:AC | acceptor_loss | 0.9900 |
AlphaMissense
5101 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:4306176:T:C | F432L | 1.000 |
| 4:4306178:C:A | F432L | 1.000 |
| 4:4306178:C:G | F432L | 1.000 |
| 4:4313061:C:A | H441Q | 1.000 |
| 4:4313061:C:G | H441Q | 1.000 |
| 4:4315637:T:C | F460L | 1.000 |
| 4:4315639:T:A | F460L | 1.000 |
| 4:4315639:T:G | F460L | 1.000 |
| 4:4315811:T:C | F488L | 1.000 |
| 4:4315813:T:A | F488L | 1.000 |
| 4:4315813:T:G | F488L | 1.000 |
| 4:4315895:T:C | F516L | 1.000 |
| 4:4315897:T:A | F516L | 1.000 |
| 4:4315897:T:G | F516L | 1.000 |
| 4:4320732:T:C | F572L | 1.000 |
| 4:4320734:T:A | F572L | 1.000 |
| 4:4320734:T:G | F572L | 1.000 |
| 4:4303046:T:C | F404L | 0.999 |
| 4:4303048:T:A | F404L | 0.999 |
| 4:4303048:T:G | F404L | 0.999 |
| 4:4303071:T:C | L412P | 0.999 |
| 4:4303073:C:A | H413N | 0.999 |
| 4:4303073:C:G | H413D | 0.999 |
| 4:4303080:G:C | R415P | 0.999 |
| 4:4303085:C:G | H417D | 0.999 |
| 4:4303087:T:A | H417Q | 0.999 |
| 4:4303087:T:G | H417Q | 0.999 |
| 4:4306149:T:C | F423L | 0.999 |
| 4:4306151:T:A | F423L | 0.999 |
| 4:4306151:T:G | F423L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000133948 (4:4319132 A>G), RS1000159393 (4:4292113 C>G), RS1000223465 (4:4296894 G>A), RS1000312132 (4:4307904 C>G,T), RS1000466940 (4:4291941 C>T), RS1000497713 (4:4291134 G>T), RS1000502222 (4:4317945 A>G,T), RS1001085566 (4:4307358 G>C,T), RS1001111313 (4:4301041 G>A), RS1001142612 (4:4299803 G>T), RS1001368327 (4:4295912 A>G), RS1001391622 (4:4306120 T>A,C), RS1001444812 (4:4299576 G>A), RS1001552014 (4:4310877 A>G), RS1001613941 (4:4311287 A>G)
Disease associations
OMIM: gene MIM:616238 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005174_9 | Coronary artery calcified atherosclerotic plaque score in type 2 diabetes | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004723 | coronary artery calcification |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD00 | HEK293 eGFP-ZBTB49 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.